Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05180201Phase 2Completed

SEPSIS: L. Plantarum Trial

Role: collaborator

NCT04012190Completed

SEPSIS Observational Cohort Study in Young Infants in Bangladesh

Role: collaborator

NCT04094831Not ApplicableUnknown

Community-based Screening of Chronic Kidney Disease (CKD) and Measure the Impact of Health Education

Role: collaborator

NCT04851808Unknown

Chronic Respiratory Disease Burden in Bangladesh

Role: lead

NCT03876249Unknown

The Long-term Effect of RSV Infection

Role: lead

All 5 trials loaded